Presentado en HealthCity

HealthCity es la publicación en línea del Boston Medical Center que explora los problemas más apremiantes en el cuidado de la salud. En HealthCity, creemos que la atención médica debe transformarse para volverse más equitativa, sostenible y de código abierto.

Más sobre mí

Dr. Tuhina Neogi is Chief of Rheumatology at Boston Medical Center, and is a Professor of Medicine and of Epidemiology at Boston University Schools of Medicine (BUSM) and of Public Health (BUSPH). As a rheumatologist and PhD-trained epidemiologist, her research focuses on osteoarthritis and gout, pain mechanisms in osteoarthritis, and methodologic issues of relevance for rheumatic diseases. She is a past chair of the FDA Arthritis Advisory Committee, serves or has served on the boards of international societies (Crystal-Associated Diseases Network (G-CAN), Osteoarthritis Research Society International (OARSI)), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. Her work was recognized with the 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research. She has led or engaged in development of new classification criteria for a number of rheumatic diseases, and has led national ACR treatment guidelines for gout and osteoarthritis. In addition to research and clinical care, Dr. Neogi mentors early stage researchers.

  • Intereses Especiales

    Rheumatology and Internist
  • Ubicación

    725 Albany Street
    6th Floor, Suite 6B
    Boston, MA 02118

Mis afiliaciones

Boston University

Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.

See my Boston University Profile